[Tobacco cessation: one of the most effective medical measures].
Tabakentwöhnung – eine der effektivsten medizinischen Maßnahmen.
Assessment of smoking status
Brief advice
Electronic nicotine delivery systems
Nicotine replacement therapy
Receptors, nicotinic/partial agonists
Journal
Innere Medizin (Heidelberg, Germany)
ISSN: 2731-7099
Titre abrégé: Inn Med (Heidelb)
Pays: Germany
ID NLM: 9918384885306676
Informations de publication
Date de publication:
06 Mar 2024
06 Mar 2024
Historique:
accepted:
13
02
2024
medline:
6
3
2024
pubmed:
6
3
2024
entrez:
6
3
2024
Statut:
aheadofprint
Résumé
Tobacco smoking is widespread in Germany. An increase in the number of teenagers and young adults that smoke has recently been a cause for concern. The high prevalence in Germany is contrasted by inadequate preventive measures compared to international standards. Smoking behavior should always be inquired about and documented in the same way as vital signs. All smokers, regardless of the reason for contact and motivation, should receive short, low-threshold advice, e.g. using the ABC approach (ask, brief advice, cessation). In addition to repeated advice and referral to further services, the use of nicotine replacement or drug therapy is essential for the success of quitting. The combination of long- and short-acting nicotine replacement products doubles the success rate. Electronic nicotine delivery systems are not recommended for smoking cessation. Tabakrauchen ist in Deutschland weitverbreitet. Sorge bereitet zuletzt ein Anstieg rauchender Jugendlicher und junger Erwachsener. Der hohen Prävalenz stehen die im internationalen Vergleich unzureichenden präventiven Maßnahmen in Deutschland konträr gegenüber. Das Rauchverhalten sollte analog einem Vitalzeichen immer erfragt und dokumentiert werden. Bei allen Rauchenden sollte unabhängig von Kontaktanlass und Motivation eine niedrigschwellige Kurzberatung erfolgen, beispielsweise nach dem ABC-Ansatz („ask, brief advice, cessation“). Für den Erfolg einer Entwöhnung ist neben wiederholten Gesprächen und der Vermittlung an weiterführende Angebote der Einsatz einer Nikotinersatztherapie bzw. medikamentösen Behandlung essenziell. Die Kombination von lang und kurz wirksamen Nikotinersatzpräparaten verdoppelt die Erfolgsrate. Elektronische Nikotininhalationssysteme werden für die Tabakentwöhnung nicht empfohlen.
Autres résumés
Type: Publisher
(ger)
Tabakrauchen ist in Deutschland weitverbreitet. Sorge bereitet zuletzt ein Anstieg rauchender Jugendlicher und junger Erwachsener. Der hohen Prävalenz stehen die im internationalen Vergleich unzureichenden präventiven Maßnahmen in Deutschland konträr gegenüber. Das Rauchverhalten sollte analog einem Vitalzeichen immer erfragt und dokumentiert werden. Bei allen Rauchenden sollte unabhängig von Kontaktanlass und Motivation eine niedrigschwellige Kurzberatung erfolgen, beispielsweise nach dem ABC-Ansatz („ask, brief advice, cessation“). Für den Erfolg einer Entwöhnung ist neben wiederholten Gesprächen und der Vermittlung an weiterführende Angebote der Einsatz einer Nikotinersatztherapie bzw. medikamentösen Behandlung essenziell. Die Kombination von lang und kurz wirksamen Nikotinersatzpräparaten verdoppelt die Erfolgsrate. Elektronische Nikotininhalationssysteme werden für die Tabakentwöhnung nicht empfohlen.
Identifiants
pubmed: 38446181
doi: 10.1007/s00108-024-01683-6
pii: 10.1007/s00108-024-01683-6
doi:
Types de publication
English Abstract
Journal Article
Langues
ger
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.
Références
Kurz C, Osterloh F (2023) Vorbeugen statt Heilen. DÄB 120:B249–B254
Assunta M (2021) Global Tobacco Industry Interference Index 2021. Global Center for Good Governance in Tobacco Control. GGTC, Bangkok, Thailand
Joossens L, Feliu A, Fernandez E (2022) The Tobacco Control Scale 2019 in Europe. Association of European Cancer Leagues CIoO
https://www.debra-study.info . Zugegriffen: 4. Dez. 2023
Hanewinkel R, Hansen J (2023) Use of tobacco cigarettes, e‑cigarettes, and shishas among children and adolescents: Results of the ‘Praventionsradar’ from 2016 to 2023. Pneumologie
Batra A, Kiefer F, Kopp I et al (2021) S3-Leitlinie Rauchen und Tabakabhängigkeit: Screening, Diagnostik und Behandlung. 076-006
Hartmann-Boyce J, Lindson N, Butler AR et al (2022) Electronic cigarettes for smoking cessation. Cochrane Database Syst Rev 11:CD10216
pubmed: 36384212
Hughes JR, Keely J, Naud S (2004) Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction 99:29–38
pubmed: 14678060
doi: 10.1111/j.1360-0443.2004.00540.x
Kotz D, Batra A, Kastaun S (2020) Smoking Cessation Attempts and Common Strategies Employed. Dtsch Ärztebl Int 117:7–13
pubmed: 32008606
pmcid: 7008148
Mühlig SFL, Winkler D, Vorbeck M, Mackert J, Bickhardt J, Heindl T (2017) Zwischenergebnisse der ATEMM-Studie der AOKplus zur vollfinanzierten Tabakentwöhnung bei COPD-Patienten. Pneumologie 71(S 01):S1–S125
Khadjesari Z, Brown TJ, Ramsey AT et al (2022) Novel Implementation Strategy to Electronically Screen and Signpost Patients to Health Behavior Apps: Mixed Methods Implementation Study (OptiMine Study). JMIR Form Res 6:e34271
pubmed: 35816374
pmcid: 9315888
doi: 10.2196/34271
Bernstein SL, Weiss J, Dewitt M et al (2019) A randomized trial of decision support for tobacco dependence treatment in an inpatient electronic medical record: clinical results. Implement Sci 14:8
pubmed: 30670043
pmcid: 6343239
doi: 10.1186/s13012-019-0856-8
Rigotti NA, Chang Y, Davis EM et al (2022) Comparative Effectiveness of Postdischarge Smoking Cessation Interventions for Hospital Patients: The Helping HAND 4 Randomized Clinical Trial. JAMA Intern Med 182:814–824
pubmed: 35759282
pmcid: 9237801
doi: 10.1001/jamainternmed.2022.2300
Mullen KA, Walker KL, Hobler LA et al (2021) Performance Obligations to Improve Delivery of Hospital-Initiated Smoking Cessation Interventions: A Before-and-After Evaluation. Nicotine Tob Res 23:77–84
pubmed: 31563965
doi: 10.1093/ntr/ntz186
Stead LF, Buitrago D, Preciado N et al (2013) Physician advice for smoking cessation. Cochrane Database Syst Rev 2013:CD165
pubmed: 23728631
pmcid: 7064045
Mcrobbie H, Bullen C, Glover M et al (2008) New Zealand smoking cessation guidelines. N Z Med J 121:57–70
pubmed: 18574510
Fiore MC, Jaen CR (2008) A clinical blueprint to accelerate the elimination of tobacco use. JAMA 299:2083–2085
pubmed: 18460668
doi: 10.1001/jama.299.17.2083
Cobos-Campos R, Cordero-Guevara JA, Apinaniz A et al (2023) The Impact of Digital Health on Smoking Cessation. Interact J Med Res 12:e41182
pubmed: 36920468
pmcid: 10131696
doi: 10.2196/41182
Rupp A, Hering T, Bubeck A et al (2023) Guideline-based digital smoking cessation with computer, tablet or smartphone. Dtsch Med Wochenschr 148:e29–e36
pubmed: 36564019
Lancaster T, Stead LF (2017) Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev 3:CD1292
pubmed: 28361496
Hartmann-Boyce J, Chepkin SC, Ye W et al (2018) Nicotine replacement therapy versus control for smoking cessation. Cochrane Database Syst Rev 5:CD146
pubmed: 29852054
Windle SB, Filion KB, Mancini JG et al (2016) Combination Therapies for Smoking Cessation: A Hierarchical Bayesian Meta-Analysis. Am J Prev Med 51:1060–1071
pubmed: 27617367
doi: 10.1016/j.amepre.2016.07.011
Lindson N, Theodoulou A, Ordonez-Mena JM et al (2023) Pharmacological and electronic cigarette interventions for smoking cessation in adults: component network meta-analyses. Cochrane Database Syst Rev 9:CD15226
pubmed: 37696529
Theodoulou A, Chepkin SC, Ye W et al (2023) Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 6:CD13308
pubmed: 37335995
Livingstone-Banks J, Fanshawe TR, Thomas KH et al (2023) Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev 5:CD6103
pubmed: 37142273
Jorenby DE, Hays JT, Rigotti NA et al (2006) Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial. JAMA 296:56–63
pubmed: 16820547
doi: 10.1001/jama.296.1.56
Anthenelli RM, Benowitz NL, West R et al (2016) Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial. Lancet 387:2507–2520
pubmed: 27116918
doi: 10.1016/S0140-6736(16)30272-0
Kotz D, Viechtbauer W, Simpson C et al (2015) Cardiovascular and neuropsychiatric risks of varenicline: a retrospective cohort study. Lancet Respir Med 3:761–768
pubmed: 26355008
pmcid: 4593936
doi: 10.1016/S2213-2600(15)00320-3
Howes S, Hartmann-Boyce J, Livingstone-Banks J et al (2020) Antidepressants for smoking cessation. Cochrane Database Syst Rev 4:CD31
pubmed: 32319681
Hajizadeh A, Howes S, Theodoulou A et al (2023) Antidepressants for smoking cessation. Cochrane Database Syst Rev 5:CD31
pubmed: 37230961
Stead LF, Koilpillai P, Fanshawe TR et al (2016) Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Database Syst Rev 3:CD8286
pubmed: 27009521
Nvl-003 A-R‑N (2021) Nationale Versorgungsleitlinie COPD
https://www.g-ba.de/presse/pressemitteilungen-meldungen/1034/ . Zugegriffen: 4. Dez. 2023
Raspe M, Bals R, Bolukbas S et al (2023) Smoking cessation in hospitalised patients—Initiate among inpatients, continue when outpatients—A Position Paper by the German Respiratory Society (DGP) Taskforce for Smoking Cessation. Pneumologie 77:341–349
pubmed: 37186277
Van Westen-Lagerweij NA, Hipple Walters BJ, Potyka F et al (2023) Proactive Referral to Behavioral Smoking Cessation Programs by Healthcare Staff: A Systematic Review. Nicotine Tob Res 25:849–858
pubmed: 36394282
doi: 10.1093/ntr/ntac262
Andreas S, Kotz D, Batra A et al (2023) Smoking Cessation in Patients with COPD. Pneumologie 77:206–219
pubmed: 36958341
General S (2020) Smoking Cessation: A Report of the Surgeon General. Services UDoHaH, Washington (DC)
Andreas S, Rittmeyer A, Hinterthaner M et al (2013) Smoking Cessation in Lung Cancer-Achievable and Effective. Dtsch Ärztebl Int 110:719–724
pubmed: 24222790
pmcid: 3822707
Caini S, Del Riccio M, Vettori V et al (2022) Quitting Smoking At or Around Diagnosis Improves the Overall Survival of Lung Cancer Patients: A Systematic Review and Meta-Analysis. J Thorac Oncol 17:623–636
pubmed: 34995798
doi: 10.1016/j.jtho.2021.12.005
Reinhardt C, Harden M, Herrmann-Lingen C et al (2022) Smoking cessation by combined medication and counselling: a feasibility study in lung cancer patients. BMC Pulm Med 22:252
pubmed: 35761222
pmcid: 9235273
doi: 10.1186/s12890-022-02048-1
Park ER, Perez GK, Regan S et al (2020) Effect of Sustained Smoking Cessation Counseling and Provision of Medication vs Shorter-term Counseling and Medication Advice on Smoking Abstinence in Patients Recently Diagnosed With Cancer: A Randomized Clinical Trial. JAMA 324:1406–1418
pubmed: 33048154
pmcid: 8094414
doi: 10.1001/jama.2020.14581
Deutsche Gesellschaft Fur Pneumologie Und Beatmungsmedizin in Zusammenarbeit Mit Medizinischen Fachgesellschaften Und Organisationen: Deutsche Gesellschaft Fur Innere M, Deutsche Gesellschaft Fur Kardiologie – Herz- Und K, Deutsche Gesellschaft Fur Angiologie – Gesellschaft Fur G et al (2022) German Respiratory Society Position Statement: Recommondations for handling electronic cigarettes (e-cigarettes). Pneumologie 76:473–478
Pisinger C, Dagli E, Filippidis FT et al (2019) ERS and tobacco harm reduction. Eur Respir J 54:
Hanewinkel R (2023) Health risks of e‑cigarettes. MMW Fortschr Med 165:65–66
pubmed: 36759479
doi: 10.1007/s15006-023-2249-9
Wills TA, Soneji SS, Choi K et al (2021) E‑cigarette use and respiratory disorders: an integrative review of converging evidence from epidemiological and laboratory studies. Eur Respir J 57:
Bhatta DN, Glantz SA (2020) Association of E‑Cigarette Use With Respiratory Disease Among Adults: A Longitudinal Analysis. Am J Prev Med 58:182–190
pubmed: 31859175
doi: 10.1016/j.amepre.2019.07.028
Osei AD, Mirbolouk M, Orimoloye OA et al (2020) Association Between E‑Cigarette Use and Chronic Obstructive Pulmonary Disease by Smoking Status: Behavioral Risk Factor Surveillance System 2016 and 2017. Am J Prev Med 58:336–342
pubmed: 31902685
pmcid: 9843649
doi: 10.1016/j.amepre.2019.10.014
Bullen C, Howe C, Laugesen M et al (2013) Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet 382:1629–1637
pubmed: 24029165
doi: 10.1016/S0140-6736(13)61842-5
Oelsner EC, Balte PP, Bhatt SP et al (2020) Lung function decline in former smokers and low-intensity current smokers: a secondary data analysis of the NHLBI Pooled Cohorts Study. Lancet Respir Med 8:34–44
pubmed: 31606435
doi: 10.1016/S2213-2600(19)30276-0
Simmons MS, Connett JE, Nides MA et al (2005) Smoking reduction and the rate of decline in FEV(1): results from the Lung Health Study. Eur Respir J 25:1011–1017
pubmed: 15929955
doi: 10.1183/09031936.05.00086804
Banks E, Yazidjoglou A, Brown S et al (2023) Electronic cigarettes and health outcomes: umbrella and systematic review of the global evidence. Med J Aust 218:267–275
pubmed: 36939271
doi: 10.5694/mja2.51890
Van Den Brand FA, Nagelhout GE, Reda AA et al (2017) Healthcare financing systems for increasing the use of tobacco dependence treatment. Cochrane Database Syst Rev 9:CD4305
pubmed: 28898403